Skip to main navigation Skip to search Skip to main content

Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial

  • Usha S. Perepu
  • , Isaac Chambers
  • , Abdul Wahab
  • , Patrick Ten Eyck
  • , Chaorong Wu
  • , Sanjana Dayal
  • , Grerk Sutamtewagul
  • , Steven R. Bailey
  • , Lori J. Rosenstein
  • , Steven R. Lentz

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science